Structural transitions and oligomerization along polyalanine fibril formation pathways from computer simulations

Proteins: Structure, Function and Bioinformatics

Volumn 80, Issue 6, 2012, Pages 1582-1597

  Phelps, Erin M ^a   Hall, Carol K ^a  

^a North Carolina State University   (United States)

Author keywords

Amyloid; Computer simulations; Fibril formation pathway; Protein aggregation

Indexed keywords

ALANINE; MONOMER; POLYPEPTIDE;

ARTICLE; BETA SHEET; COMPUTER SIMULATION; FIBER; HYBRID; MOLECULAR DYNAMICS; MOLECULAR SIZE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN STRUCTURE;

AMYLOID; MOLECULAR DYNAMICS SIMULATION; PEPTIDES; PROTEIN CONFORMATION; TEMPERATURE;

EID: 84860627561     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24052     Document Type: Article

References (75)

1. Adamcik J, Jung JM, Flakowski J, De Los Rios P, Dietler G, Mezzenga R. Understanding amyloid aggregation by statistical analysis of atomic force microscopy images. Nat Nanotechnol 2010; 5: 423-428.
2. Bieler S, Estrada L, Lagos R, Baeza M, Castilla J, Soto C. Amyloid formation modulates the biological activity of a bacterial protein. J Biol Chem 2005; 280: 26880-26885.
3. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo JS, Taddei N, Ramponi G, Dobson CM, Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002; 416: 507-511.
4. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006; 75: 333-366.
5. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8: 101-112.
6. Kodali R, Wetzel R. Polymorphism in the intermediates and products of amyloid assembly. Curr Opin Struct Biol 2007; 17: 48-57.
7. Lansbury PT, Lashuel HA. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 2006; 443: 774-779.
8. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 2005; 435: 773-778.
9. Petkova AT, Yau WM, Tycko R. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry 2006; 45: 498-512.
10. Serpell LC, Sunde M, Benson MD, Tennent GA, Pepys MB, Fraser PE. The protofilament substructure of amyloid fibrils. J Mol Biol 2000; 300: 1033-1039.
11. Chiti F, Dobson CM. Amyloid formation by globular proteins under native conditions. Nat Chem Biol 2009; 5: 15-22.
12. Gonzalez-Velasquez FJ, Kotarek JA, Moss MA. Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers. J Neurochem 2008; 107: 466-477.
13. Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, Head E, Hall J, Glabe C. Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem 2009; 284: 4230-4237.
14. Kelly JW. Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases. Structure 1997; 5: 595-600.
15. Ono K, Condron MM, Teplow DB. Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci USA 2009; 106: 14745-14750.
16. Walsh DM, Selkoe DJ. A beta oligomers-a decade of discovery. J Neurochem 2007; 101: 1172-1184.
17. Auer S, Meersman F, Dobson CM, Vendruscolo M. A generic mechanism of emergence of amyloid protofilaments from disordered oligomeric aggregates. PLoS Comput Biol 2008; 4:e100022.
18. Auer S, Dobson CM, Vendruscolo M. Characterization of the nucleation barriers for protein aggregation and amyloid formation. Hfsp J 2007; 1: 137-146.
19. Pallitto MM, Murphy RM. A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys J 2001; 81: 1805-1822.
20. Glabe CG. Structural classification of toxic amyloid oligomers. J Biol Chem 2008; 283: 29639-29643.
21. Rangachari V, Moore BD, Reed DK, Sonoda LK, Bridges AW, Conboy E, Hartigan D, Rosenberry TL. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfatet. Biochemistry 2007; 46: 12451-12462.
22. Necula M, Breydo L, Milton S, Kayed R, van der Veer WE, Tone P, Glabe CG. Methylene blue inhibits amyloid A beta oligomerization by promoting fibrillization. Biochemistry 2007; 46: 8850-8860.
23. Necula M, Kayed R, Milton S, Glabe CG. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 2007; 282: 10311-10324.
24. Chebaro Y, Dong X, Laghaei R, Derreumaux P, Mousseau N. Replica exchange molecular dynamics simulations of coarse-grained proteins in implicit solvent. J Phys Chem B 2009; 113: 267-274.
25. Derreumaux P, Mousseau N. Coarse-grained protein molecular dynamics simulations. J Chem Phys 2007; 126:025101.
26. Urbanc B, Betnel M, Cruz L, Bitan G, Teplow DB. Elucidation of amyloid beta-protein oligomerization mechanisms: discrete molecular dynamics study. J Am Chem Soc 2010; 132: 4266-4280.
27. Wei GH, Song W, Derreumaux P, Mousseau N. Self-assembly of amyloid-forming peptides by molecular dynamics simulations. Front Biosci 2008; 13: 5681-5692.
28. Marchut AJ, Hall CK. Spontaneous formation of annular structures observed in molecular dynamics simulations of polyglutamine peptides. Comput Biol Chem 2006; 30: 215-218.
29. Cellmer T, Douma R, Huebner A, Prausnitz J, Blanch H. Kinetic studies of protein L aggregation and disaggregation. Biophys Chem 2007; 125: 350-359.
30. Miller Y, Ma BY, Nussinov R. Synergistic interactions between repeats in tau protein and A beta amyloids may be responsible for accelerated aggregation via polymorphic states. Biochemistry 2011; 50: 5172-5181.
31. Miller Y, Ma BY, Nussinov R. Polymorphism of Alzheimer's A beta(17-42) (p3) oligomers: the importance of the turn location and its conformation. Biophys J 2009; 97: 1168-1177.
32. Straub JE, Thirumalai D. Toward a molecular theory of early and late events in monomer to amyloid fibril formation. In: Leone SR, Cremer PS, Groves JT, Johnson MA, editors. Annual review of physical chemistry, Vol. 62. 2011: 437-463.
33. Straub JE, Thirumalai D. Principles governing oligomer formation in amyloidogenic peptides. Curr Opin Struct Biol 2010; 20: 187-195.
34. Tarus B, Straub JE, Thirumalai D. Probing the initial stage of aggregation of the A beta(10-35)-protein: assessing the propensity for peptide dimerization. J Mol Biol 2005; 345: 1141-1156.
35. Cerda-Costa N, Esteras-Chopo A, Aviles FX, Serrano L, Villegas V. Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. J Mol Biol 2007; 366: 1351-1363.
36. Chen SM, Ferrone FA, Wetzel R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci USA 2002; 99: 11884-11889.
37. Bellesia G, Shea JE. Effect of beta-sheet propensity on peptide aggregation. J Chem Phys 2009; 130: 145103.
38. Bellesia G, Shea JE. Diversity of kinetic pathways in amyloid fibril formation. J Chem Phys 2009; 131: 111102.
39. Knowles TPJ, Waudby CA, Devlin GL, Cohen SIA, Aguzzi A, Vendruscolo M, Terentjev EM, Welland ME, Dobson CM. An analytical solution to the kinetics of breakable filament assembly. Science 2009; 326: 1533-1537.
40. Lee CC, Nayak A, Sethuraman A, Belfort G, McRae GJ. A three-stage kinetic model of amyloid fibrillation. Biophys J 2007; 92: 3448-3458.
41. Murphy RM. Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins. Biochim Biophys Acta Biomembr 2007; 1768: 1923-1934.
42. Lomakin A, Teplow DB, Kirschner DA, Benedek GB. Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci USA 1997; 94: 7942-7947.
43. Powers ET, Powers DL. The kinetics of nucleated polymerizations at high concentrations: amyloid fibril formation near and above the "supercritical concentration". Biophys J 2006; 91: 122-132.
44. Roberts CJ, Darrington RT, Whitley MB. Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life. J Pharm Sci 2003; 92: 1095-1111.
45. Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 2003; 26: 267-298.
46. Gibson TJ, Murphy RM. Inhibition of insulin fibrillogenesis with targeted peptides. Protein Sci 2006; 15: 1133-1141.
47. Bhattacharyya AM, Thakur AK, Wetzel R. Polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc Natl Acad Sci USA 2005; 102: 15400-15405.
48. Cannon MJ, Williams AD, Wetzel R, Myszka DG. Kinetic analysis of beta-amyloid fibril elongation. Anal Biochem 2004; 328: 67-75.
49. Kelly JW. Mechanisms of amyloidogenesis. Nat Struct Biol 2000; 7: 824-826.
50. Bernacki JP, Murphy RM. Model discrimination and mechanistic interpretation of kinetic data in protein aggregation studies. Biophys J 2009; 96: 2871-2887.
51. Davis TJ, Soto-Ortega DD, Kotarek JA, Gonzalez-Velasquez FJ, Sivakumar K, Wu LY, Wang Q, Moss MA. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight. Mol Pharmacol 2009; 76: 405-413.
52. Vitalis A, Lyle N, Pappu RV. Thermodynamics of beta-sheet formation in polyglutamine. Biophys J 2009; 97: 303-311.
53. Vitalis A, Wang XL, Pappu RV. Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization. J Mol Biol 2008; 384: 279-297.
54. Williamson TE, Vitalis A, Crick SL, Pappu RV. Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin. J Mol Biol 2010; 396: 1295-1309.
55. Krishnan R, Lindquist SL. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 2005; 435: 765-772.
56. Mukhopadhyay S, Krishnan R, Lemke EA, Lindquist S, Deniz AA. A natively unfolded yeast prion monomer adopts an ensemble of collapsed and rapidly fluctuating structures. Proc Natl Acad Sci USA 2007; 104: 2649-2654.
57. Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, Serpell L, Arnsdorf MF, Lindquist SL. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000; 289: 1317-1321.
58. Ding F, Dokholyan NV, Buldyrev SV, Stanley HE, Shakhnovich EI. Molecular dynamics simulation of the SH3 domain aggregation suggests a generic amyloidogenesis mechanism. J Mol Biol 2002; 324: 851-857.
59. Blondelle SE, Forood B, Houghten RA, PerezPaya E. Polyalanine-based peptides as models for self-associated beta-pleated-sheet complexes. Biochemistry 1997; 36: 8393-8400.
60. Nguyen HD, Hall CK. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci USA 2004; 101: 16180-16185.
61. Nguyen HD, Hall CK. Phase diagrams describing fibrillization by polyalanine peptides. Biophys J 2004; 87: 4122-4134.
62. Nguyen HD, Hall CK. Kinetics of fibril formation by polyalanine peptides. J Biol Chem 2005; 280: 9074-9082.
63. Nguyen HD, Hall CK. Spontaneous fibril formation by polyalanines; discontinuous molecular dynamics simulations. J Am Chem Soc 2006; 128: 1890-1901.
64. Cheon M, Chang I, Mohanty S, Luheshi LM, Dobson CM, Vendruscolo M, Favrin G. Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput Biol 2007; 3: 1727-1738.
65. Smith AV, Hall CK. Alpha-helix formation: discontinuous molecular dynamics on an intermediate-resolution protein model. Proteins-Struct Funct Genet 2001; 44: 344-360.
66. Smith AV, Hall CK. Assembly of a tetrameric alpha-helical bundle: computer simulations on an intermediate-resolution protein model. Proteins-Struct Funct Genet 2001; 44: 376-391.
67. Nguyen HD, Marchut AJ, Hall CK. Solvent effects on the conformational transition of a model polyalanine peptide. Protein Sci 2004; 13: 2909-2924.
68. Smith SW, Hall CK, Freeman BD. Molecular dynamics for polymeric fluids using discontinuous potentials. J Comput Phys 1997; 134: 16-30.
69. Alder BJ, Wainwright TE. Studies in molecular dynamics. I. General method. J Chem Phys 1959; 31: 459-466.
70. Rapaport DC. Molecular-dynamics study of a polymer-chain in solution. J Chem Phys 1979; 71: 3299-3303.
71. Rapaport DC. Molecular-dynamics simulation of polymer-chains with excluded volume. J Phys A-Math Gen 1978; 11: L213-L217.
72. Andersen HC. Molecular-dynamics simulations at constant pressure and-or temperature. J Chem Phys 1980; 72: 2384-2393.
73. Lee CC, Walters RH, Murphy RM. Reconsidering the mechanism of polyglutamine peptide aggregation. Biochemistry 2007; 46: 12810-12820.
74. Zhang JN, Muthukumar M. Simulations of nucleation and elongation of amyloid fibrils. J Chem Phys 2009; 130: 035102.
75. Pellarin R, Guarnera E, Caflisch A. Pathways and intermediates of amyloid fibril formation. J Mol Biol 2007; 374: 917-924.